皮肤微生物与银屑病发病相关性的研究进展
Research Progress on the Correlation between Skin Microbiome and Pathogenesis of Psoriasis
DOI: 10.12677/ACM.2022.122182, PDF,   
作者: 边慧莹, 周 婧*:哈尔滨医科大学附属第二医院皮肤科,黑龙江 哈尔滨
关键词: 银屑病皮肤微生物发病机制Toll样受体抗菌肽Psoriasis Skin Microbiome Pathogenesis TLRs Antimicrobial Peptides
摘要: 银屑病的病因极其复杂,涉及遗传、免疫与环境等多种因素。近年来越来越多的研究发现,银屑病患者存在皮肤微生物群失调,发病机制可能涉及对皮肤微生物免疫耐受的崩溃。但这些研究在取样方法、部位和微生物分析方法上各持己见,尚无统一标准。迄今为止尚未发现皮肤微生物和银屑病之间的相关性,即微生物的组成变化是否与银屑病的发病具有因果关系。本文对国内外利用现代测序技术鉴定银屑病皮肤微生物多样性的研究进行梳理和分析,旨在了解银屑病发病机制,明确当前的研究进展和存在的问题,为进一步的研究提出建议。
Abstract: Psoriasis is a disease with complex etiology and its pathogenesis involves a variety of factors such as heredity, immunity and environment. In recent years, more and more studies have shown that patients with psoriasis have obvious dysbiosis of skin microbiome. The pathogenesis of psoriasis may involve the collapse of immune tolerance to skin microbiome. However, these studies are different in sampling methods, sampling sites and microbial analysis methods and there is no unified standard. So far, no clear link has been found between skin microbiome and psoriasis and whether there is a causal relationship between changes in microbial composition and psoriasis. In this review, the domestic and foreign studies on the identification of skin microbial diversity of psoriasis by modern sequencing technology were summarized and analyzed, aiming to understand the pathogenesis of psoriasis, clarify the current research progress and existing problems, and put forward suggestions for further research.
文章引用:边慧莹, 周婧. 皮肤微生物与银屑病发病相关性的研究进展[J]. 临床医学进展, 2022, 12(2): 1248-1254. https://doi.org/10.12677/ACM.2022.122182

参考文献

[1] Christophers, E. (2001) Psoriasis—Epidemiology and Clinical Spectrum. Clinical and Experimental Dermatology, 26, 314-320. [Google Scholar] [CrossRef] [PubMed]
[2] Owczarczyk-Saczonek, A., Czerwińska, J. and Placek, W. (2018) The Role of Regulatory T Cells and Anti-Inflammatory Cytokines in Psoriasis. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 27, 17-23. [Google Scholar] [CrossRef
[3] Iannone, L.F., Bennardo, L., Palleria, C., Roberti, R., De Sarro, C., Naturale, M.D., et al. (2020) Safety Profile of Biologic Drugs for Psoriasis in Clinical Practice: An Italian Prospective Pharmacovigilance Study. PLoS ONE, 15, e0241575. [Google Scholar] [CrossRef] [PubMed]
[4] Lee, F.I., Bellary, S.V. and Francis, C. (1990) Increased Occurrence of Psoriasis in Patients with Crohn’s Disease and Their Relatives. American Journal of Gastroenterology, 85, 962-963.
[5] Preus, H.R., Khanifam, P., Kolltveit, K., Mørk, C. and Gjermo, P. (2010) Periodontitis in Psoriasis Patients: A Blinded, Case-Controlled Study. Acta Odontologica Scandinavica, 68, 165-170. [Google Scholar] [CrossRef] [PubMed]
[6] Fry, L., Baker, B.S., Powles, A.V., Fahlen, A. and Engstrand, L. (2013) Is Chronic Plaque Psoriasis Triggered by Microbiota in the Skin? British Journal of Dermatology, 169, 47-52. [Google Scholar] [CrossRef] [PubMed]
[7] Talanin, N.Y. (1998) American Academy of Dermatology 1998 Awards for Young Investigators in Dermatology. Detection of Streptococcal Antigens in Psoriasis. Journal of the American Academy of Dermatology, 39, 270-271. [Google Scholar] [CrossRef
[8] 彭琛, 陈文娟, 于宁, 高芸璐, 易雪梅, 丁杨峰. 银屑病皮肤及肠道微生态研究进展[J]. 中华皮肤科杂志, 2019, 52(2): 135-137.
[9] Grice, E.A., Kong, H.H., Conlan, S., Deming, C.B., Davis, J., Young, A.C., et al. (2009) Topographical and Temporal Diversity of the Human Skin Microbiome. Science, 324, 1190-1192. [Google Scholar] [CrossRef] [PubMed]
[10] Musthaq, S., Mazuy, A. and Jakus, J. (2018) The Microbiome in Dermatology. Clinics in Dermatology, 36, 390-398. [Google Scholar] [CrossRef] [PubMed]
[11] Grice, E.A. (2014) The Skin Microbiome: Potential for Novel Diagnostic and Therapeutic Approaches to Cutaneous Disease. Seminars in Cutaneous Medicine and Surgery, 33, 98-103. [Google Scholar] [CrossRef] [PubMed]
[12] Perez Perez, G.I., Gao, Z., Jourdain, R., Ramirez, J., Gany, F., Clavaud, C., et al. (2016) Body Site Is a More Determinant Factor than Human Population Diversity in the Healthy Skin Microbiome. PLoS ONE, 11, e0151990. [Google Scholar] [CrossRef] [PubMed]
[13] Byrd, A.L., Belkaid, Y. and Segre, J.A. (2018) The Human Skin Microbiome. Nature Reviews Microbiology, 16, 143-155. [Google Scholar] [CrossRef] [PubMed]
[14] Grice, E.A., Kong, H.H., Renaud, G., Young, A.C., Bouffard, G.G., Blakesley, R.W., et al. (2008) A Diversity Profile of the Human Skin Microbiota. Genome Research, 18, 1043-1050. [Google Scholar] [CrossRef] [PubMed]
[15] Prast-Nielsen, S., Tobin, A.M., Adamzik, K., Powles, A., Hugerth, L., Sweeney, C., et al. (2019) Investigation of the Skin Microbiome: Swabs vs. Biopsies. British Journal of Dermatology, 181, 572-579. [Google Scholar] [CrossRef] [PubMed]
[16] Nakatsuji, T., Chiang, H.I., Jiang, S.B., Nagarajan, H., Zengler, K. and Gallo, R.L. (2013) The Microbiome Extends to Subepidermal Compartments of Normal Skin. Nature Communications, 4, Article No. 1431. [Google Scholar] [CrossRef] [PubMed]
[17] Brooks, J.P., Edwards, D.J., Harwich Jr., M.D., Rivera, M.C., Fettweis, J.M., Serrano, M.G., et al. (2015) The Truth about Metagenomics: Quantifying and Counteracting Bias in 16S rRNA Studies. BMC Microbiology, 15, Article No. 66. [Google Scholar] [CrossRef] [PubMed]
[18] Gerasimidis, K., Bertz, M., Quince, C., Brunner, K., Bruce, A., Combet, E., et al. (2016) The Effect of DNA Extraction Methodology on Gut Microbiota Research Applications. BMC Research Notes, 9, Article No. 365. [Google Scholar] [CrossRef] [PubMed]
[19] Meisel, J.S., Hannigan, G.D., Tyldsley, A.S., SanMiguel, A.J., Hodkinson, B.P., Zheng, Q., et al. (2016) Skin Microbiome Surveys Are Strongly Influenced by Experimental Design. Journal of Investigative Dermatology, 136, 947-956. [Google Scholar] [CrossRef] [PubMed]
[20] Quan, C., Chen, X.Y., Li, X., Xue, F., Chen, L.H., Liu, N., et al. (2020) Psoriatic Lesions Are Characterized by Higher Bacterial Load and Imbalance between Cutibacterium and Corynebacterium. Journal of the American Academy of Dermatology, 82, 955-961. [Google Scholar] [CrossRef] [PubMed]
[21] Fyhrquist, N., Muirhead, G., Prast-Nielsen, S., Jeanmougin, M., Olah, P., Skoog, T., et al. (2019) Microbe-Host Interplay in Atopic Dermatitis and Psoriasis. Nature Communications, 10, Article No. 4703. [Google Scholar] [CrossRef] [PubMed]
[22] Chang, H.W., Yan, D., Singh, R., Liu, J., Lu, X., Ucmak, D., et al. (2018) Alteration of the Cutaneous Microbiome in Psoriasis and Potential Role in Th17 Polarization. Microbiome, 6, Article No. 154. [Google Scholar] [CrossRef] [PubMed]
[23] Tomida, S., Nguyen, L., Chiu, B.H., Liu, J., Sodergren, E., Weinstock, G.M., et al. (2013) Pan-Genome and Comparative Genome analyses of Propionibacterium Acnes Reveal Its Genomic Diversity in the Healthy and Diseased Human Skin Microbiome. mBio, 4, e00003-13. [Google Scholar] [CrossRef
[24] Gao, Z., Tseng, C.H., Strober, B.E., Pei, Z. and Blaser, M.J. (2008) Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions. PLoS ONE, 3, e2719. [Google Scholar] [CrossRef] [PubMed]
[25] Alekseyenko, A.V., Perez-Perez, G.I., De Souza, A., Strober, B., Gao, Z., Bihan, M., et al. (2013) Community Differentiation of the Cutaneous Microbiota in Psoriasis. Microbiome, 1, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[26] Fahlén, A., Engstrand, L., Baker, B.S., Powles, A. and Fry, L. (2012) Comparison of Bacterial Microbiota in Skin Biopsies from Normal and Psoriatic Skin. Archives of Dermatological Research, 304, 15-22. [Google Scholar] [CrossRef] [PubMed]
[27] Bosi, E., Monk, J.M., Aziz, R.K., Fondi, M., Nizet, V. and Palsson, B.Ø. (2016) Comparative Genome-Scale Modelling of Staphylococcus aureus Strains Identifies Strain-Specific Metabolic Capabilities Linked to Pathogenicity. Proceedings of the National Academy of Sciences of the United States of America, 113, E3801-E3809. [Google Scholar] [CrossRef] [PubMed]
[28] Tett, A., Pasolli, E., Farina, S., Truong, D.T., Asnicar, F., Zolfo, M., et al. (2017) Unexplored Diversity and Strain-Level Structure of the Skin Microbiome Associated with Psoriasis. NPJ Biofilms and Microbiomes, 3, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
[29] Chu, H. and Mazmanian, S.K. (2013) Innate Immune Recognition of the Microbiota Promotes Host-Microbial Symbiosis. Nature Immunology, 14, 668-675. [Google Scholar] [CrossRef] [PubMed]
[30] Belkaid, Y. and Hand, T.W. (2014) Role of the Microbiota in Immunity and Inflammation. Cell, 157, 121-141. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, J.Q., Szodoray, P. and Zeher, M. (2016) Toll-Like Receptor Pathways in Autoimmune Diseases. Clinical Reviews in Allergy & Immunology, 50, 1-17. [Google Scholar] [CrossRef] [PubMed]
[32] Garcia-Rodriguez, S., Arias-Santiago, S., Perandrés-López, R., Castellote, L., Zumaquero, E., Navarro, P., et al. (2013) Increased Gene Expression of Toll-Like Receptor 4 on Peripheral Blood Mononuclear Cells in Patients with Psoriasis. Journal of the European Academy of Dermatology and Venereology, 27, 242-250. [Google Scholar] [CrossRef] [PubMed]
[33] Ma, J.Y., Shao, S. and Wang, G. (2020) Antimicrobial Peptides: Bridging Innate and Adaptive Immunity in the Pathogenesis of Psoriasis. Chinese Medical Journal, 133, 2966-2975. [Google Scholar] [CrossRef
[34] Büchau, A.S. and Gallo, R.L. (2007) Innate Immunity and Antimicrobial Defense Systems in Psoriasis. Clinics in Dermatology, 25, 616-624. [Google Scholar] [CrossRef] [PubMed]
[35] Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.H., Homey, B., et al. (2007) Plasmacytoid Dendritic Cells Sense Self-DNA Coupled with Antimicrobial Peptide. Nature, 449, 564-569. [Google Scholar] [CrossRef] [PubMed]
[36] Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., et al. (2009) Self-RNA-Antimicrobial Peptide Complexes Activate Human Dendritic Cells through TLR7 and TLR8. Journal of Experimental Medicine, 206, 1983-1994. [Google Scholar] [CrossRef] [PubMed]
[37] Morizane, S., Yamasaki, K., Mühleisen, B., Kotol, P.F., Murakami, M., Aoyama, Y., et al. (2012) Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands. Journal of Investigative Dermatology, 132, 135-143. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, L.J., Sen, G.L., Ward, N.L., Johnston, A., Chun, K., Chen, Y., et al. (2016) Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury. Immunity, 45, 119-130. [Google Scholar] [CrossRef] [PubMed]
[39] Gregorio, J., Meller, S., Conrad, C., Di Nardo, A., Homey, B., Lauerma, A., et al. (2010) Plasmacytoid Dendritic Cells Sense Skin Injury and Promote Wound Healing through Type I Interferons. Journal of Experimental Medicine, 207, 2921-2930. [Google Scholar] [CrossRef] [PubMed]
[40] Lowes, M.A., Suárez-Fariñas, M. and Krueger, J.G. (2014) Immunology of Psoriasis. Annual Review of Immunology, 32, 227-255. [Google Scholar] [CrossRef] [PubMed]
[41] Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G. and Romanelli, M. (2018) Scanning the Immunopathogenesis of Psoriasis. International Journal of Molecular Sciences, 19, Article No. 179. [Google Scholar] [CrossRef] [PubMed]
[42] Chen, G., Chen, Z.M., Fan, X.Y., Jin, Y.L., Li, X., Wu, S.R., et al. (2021) Gut-Brain-Skin Axis in Psoriasis: A Review. Dermatology and Therapy, 11, 25-38. [Google Scholar] [CrossRef] [PubMed]
[43] Tan, L., Zhao, S., Zhu, W., Wu, L., Li, J., Shen, M., et al. (2018) The Akkermansia muciniphila Is a Gut Microbiota Signature in Psoriasis. Experimental Dermatology, 27, 144-149. [Google Scholar] [CrossRef] [PubMed]
[44] O’Neill, C.A., Monteleone, G., McLaughlin, J.T. and Paus, R. (2016) The Gut-Skin Axis in Health and Disease: A Paradigm with Therapeutic Implications. BioEssays, 38, 1167-1176. [Google Scholar] [CrossRef] [PubMed]
[45] Shinno-Hashimoto, H., Hashimoto, Y., Wei, Y., Chang, L., Fujita, Y., Ishima, T., et al. (2021) Abnormal Composition of Microbiota in the Gut and Skin of Imiquimod-Treated Mice. Scientific Reports, 11, Article No. 11265. [Google Scholar] [CrossRef] [PubMed]